Senate Appropriations Committee Approves $100 Million Increase for Alzheimer's and Dementia Research Funding

Strategic Insights -

The Senate Appropriations Committee has approved a significant increase in funding for Alzheimer's and dementia research at the National Institutes of Health (NIH) for the 2026 fiscal year. The proposed legislation would bring total annual funding to $3.9 billion, marking a major milestone in the fight against Alzheimer's. This development is attributed to the strong bipartisan support from committee members, led by Chairman Susan Collins (R-Maine) and Vice Chairman Patty Murray (D-Wash.). The Alzheimer's Association and its advocacy partners have played a crucial role in advocating for increased research funding, sharing personal stories of how Alzheimer's has affected them and meeting with elected officials to urge them to invest in dementia research.

Key Takeaways:

  • The Senate Appropriations Committee has approved a $100 million increase for Alzheimer's and dementia research funding at the NIH for the 2026 fiscal year.
  • The proposed legislation would bring total annual funding to $3.9 billion.
  • The increase in funding is attributed to strong bipartisan support from committee members, led by Chairman Susan Collins (R-Maine) and Vice Chairman Patty Murray (D-Wash.).
  • The Alzheimer's Association and its advocacy partners have spent the year holding hundreds of meetings with elected officials, sharing personal stories of how Alzheimer's has affected them.
  • The proposed legislation also includes $41.5 million for the Centers for Disease Control and Prevention (CDC) to fund the Healthy Brain Initiative and the BOLD Infrastructure for Alzheimer's Act.
  • Alzheimer's researchers are providing new insight into the factors impacting brain health, including the potential benefits of lifestyle changes such as a healthy diet, physical activity, cognitive stimulation, and cardiovascular wellness.
  • The study results present a compelling case for investments in preventive brain health programs.
  • Reducing cognitive decline helps reduce future care costs and supports healthy, productive aging.
  • Pat McCrory, member of the Alzheimer's Task Force, emphasized that the fight against Alzheimer's is a national priority and requires sustained federal investment.

Statistics:

  • The proposed legislation would bring total annual funding for Alzheimer's and dementia research at the NIH to $3.9 billion.
  • The increase in funding represents a $100 million increase over the current year's budget.
  • The Centers for Disease Control and Prevention (CDC) would receive $41.5 million to fund the Healthy Brain Initiative and the BOLD Infrastructure for Alzheimer's Act.
  • An estimated 1,100 advocates from all 50 states attended the AIM Advocacy Forum in June to meet with their elected officials.

Sources:

  • Alzheimer's Association. "Alzheimer's Association statement on Senate Appropriations Committee approval of FY26 funding increase for Alzheimer's and dementia research."
  • Alzheimer's Association International Conference 2025 (AAIC 2025).